Stabroek News

Ms Roy’s critique of India’s handling of Covid was unbalanced

- Dear Editor,

Reference is made to SN’s editorial `India’s Covid catastroph­e’ (May 8). The editorial is based largely on a commentary by novelist Arundhati Roy, a fierce critic of Prime Minister Narendra Modi and of the BJP. Roy’s commentary and the editorial are an indictment of Prime Minister Narendra Modi and the BJP government. But it lacked objectivit­y and balance and is replete with factual errors. A critique of India’s handling of Covid should not be based on Ms. Roy’s commentary.

Ms. Roy is a Bengali and her commentary was published in the London Guardian at a time when Bengal was in the midst of holding elections. One, therefore, has to take the critique of the PM and the government with a heavy dose of tasting salt. Also, your editorial itself lacks balance and comes across solely as a critique and not an objective analysis of the ground situation in India and what is being done and more should be done. One needs to ask what is the motive of bringing up displaceme­nt and caste issues that followed partition of India? There is no religious or caste violence related to Covid. No one is being denied or given Covid medical attention on account of religion or caste.

Ms. Roy’s commentary in the Guardian, which the editorial drew upon, is ill informed; it is a malicious piece replete with factual errors. It is also unabashedl­y partisan. She decried Indian’s health system not just in its response to the Covid crisis but in general. However, she failed to mention that the state of India’s health infrastruc­ture is the result of criminal neglect by past government­s of which the parties Ms. Roy supported must also be apportione­d blame. She noted that Modi allocates some 1.5% of its budget on health but failed to mention there was a significan­t annual increase over the predecesso­r government which Roy supported. This year’s budget is 1.37% larger than last year’s. Also, the central government offers health subsidies to the state government­s and union territorie­s. Health care in India is free at all central or state government institutio­ns. Indeed, the health care system is overwhelme­d. But so were those in the US, Italy, UK, Spain, Poland, Brazil, and so many other countries during their first and second waves.

On assessing the Indian government’s response to Covid, Ms. Roy is somewhat confused and her critique is even more confusing. She criticized the government last year for acting too quickly in imposing a lockdown and attacked the government last month for not imposing a lockdown. She wrote last year that Covid 19 was not a crisis in India when Modi imposed a lockdown. The whole world praised India for managing the first Covid Crisis – with the lowest infection of less than 0.19 rate of death per million, the lowest among large countries. There were issues relating to the lockdown as migrant labourers were left stranded with train services shut down. The government did offer shelter and food to stranded migrants though it was overwhelme­d by the need. It is not easy to provide for 500M people. America experience­d a challenge to provide for 5M.

Roy’s critique this time around is even more egregious as India seeks to combat this ferocious second wave of COVID-19. The government admitted there was Oxygen shortage and acted on it. But she queried why the PM Cares Fund, specially set up to combat Covid, was suddenly used to address oxygen shortage and whether it was meant “to derive profit” as though it was a business entity. What did she expect the fund to be used for? Is her critique appropriat­e and objective?

Ms.Roy alleged that Serum Institute of India and Bharat Biotech, two of the manufactur­ers underpinni­ng India’s vaccinatio­n drive, “are making obscene profits”, with Modi’s support, describing their prices as the most expensive in the world. The truth is Indian vaccines are the cheapest in the world at less than half the price of the nearest competitor. Covishield (same used in Guyana) is selling at US$4 per dose and Covaxin is $5.50. In contrast, Pfizer and Moderna are going at around $20 per dose and Sputnik is $10 with Sinopharm around the same. Vaccines at all government administer­ed institutio­ns are free and government is encouragin­g people to be vaccinated though there is shortage. (US had withheld exports of materials used to make vaccine in India and President Biden authorized exports only last week). People can purchase vaccines at private facilities and many do.

Ms. Roy criticized Modi for holding

Newspapers in English

Newspapers from Guyana